Breaking News

NIIMBL Unveils 3 New Vaccine Manufacturing Projects

Announces $1.7 million from the Global Health Fund.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has announced approximately $1.7 million in planned project activities through the Institute’s Global Health Fund (GHF) Project Call 6.1G for three new projects focused on the development of in vitro potency assays for vaccines being produced by mRNA and/or viral vector technologies. These projects were selected to best align with key focus areas identified by NIIMBL and the Bill and Melinda Gates Foundat...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters